These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overexpression of p53 is a late event in the development of malignant melanoma. Lassam NJ; From L; Kahn HJ Cancer Res; 1993 May; 53(10 Suppl):2235-8. PubMed ID: 8485708 [TBL] [Abstract][Full Text] [Related]
4. Mutation and expression of the p53 gene in malignant melanoma cell lines. Weiss J; Schwechheimer K; Cavenee WK; Herlyn M; Arden KC Int J Cancer; 1993 Jun; 54(4):693-9. PubMed ID: 8514460 [TBL] [Abstract][Full Text] [Related]
5. Mutations of the p53 gene in human functional adrenal neoplasms. Lin SR; Lee YJ; Tsai JH J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638 [TBL] [Abstract][Full Text] [Related]
6. p53 expression in uveal malignant melanomas. Jay V; Yi Q; Hunter WS; Zielenska M Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946 [TBL] [Abstract][Full Text] [Related]
7. Chromosomal abnormalities, p53 and Bcl-2 expression and clinical outcome in choroidal melanoma. Erol N; Oner U; Artan S; Işiksoy S; Yurdakul S Melanoma Res; 2004 Dec; 14(6):473-8. PubMed ID: 15577317 [TBL] [Abstract][Full Text] [Related]
8. Expression of mutant p53 in melanoma. Stretch JR; Gatter KC; Ralfkiaer E; Lane DP; Harris AL Cancer Res; 1991 Nov; 51(21):5976-9. PubMed ID: 1933861 [TBL] [Abstract][Full Text] [Related]
9. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings. Eeles RA; Warren W; Knee G; Bartek J; Averill D; Stratton MR; Blake PR; Tait DM; Lane DP; Easton DF Oncogene; 1993 May; 8(5):1269-76. PubMed ID: 8479749 [TBL] [Abstract][Full Text] [Related]
10. Choroidal melanoma and choroidal nevus in one sibship. Neetens A; Rubbens MC; Mariën N Bull Soc Belge Ophtalmol; 1983; 207():37-43. PubMed ID: 6680044 [No Abstract] [Full Text] [Related]
11. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum. Spatz A; Giglia-Mari G; Benhamou S; Sarasin A Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the functional integrity of the p53 tumor-suppressor gene in malignant melanoma. Knopf A; Plettenberg C; Pickhard A; Bas M; Reifenberger J; Bier H; Balz V Melanoma Res; 2011 Oct; 21(5):380-8. PubMed ID: 21691232 [TBL] [Abstract][Full Text] [Related]
13. Analysis of p53 in human cutaneous melanoma cell lines. Montano X; Shamsher M; Whitehead P; Dawson K; Newton J Oncogene; 1994 May; 9(5):1455-9. PubMed ID: 8152807 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. Poremba C; Yandell DW; Metze D; Kamanabrou D; Böcker W; Dockhorn-Dworniczak B Oncol Res; 1995; 7(7-8):331-9. PubMed ID: 8747596 [TBL] [Abstract][Full Text] [Related]
15. Overexpression and mutations of p53 in metastatic malignant melanomas. Hartmann A; Blaszyk H; Cunningham JS; McGovern RM; Schroeder JS; Helander SD; Pittelkow MR; Sommer SS; Kovach JS Int J Cancer; 1996 Jul; 67(3):313-7. PubMed ID: 8707401 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the human p53 gene in malignant melanoma. Volkenandt M; Schlegel U; Nanus DM; Albino AP Pigment Cell Res; 1991 Feb; 4(1):35-40. PubMed ID: 1924172 [TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical detection of the gene p53 and p21 expression in cells of the malignant melanoma of the uvea]. Tokosová E; Hermanová M; Uhmannová R; Smardová J; Hlinomazová Z Cesk Slov Oftalmol; 2008 Jul; 64(4):153-6. PubMed ID: 18780655 [TBL] [Abstract][Full Text] [Related]
18. Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. Akslen LA; Monstad SE; Larsen B; Straume O; Ogreid D Int J Cancer; 1998 Feb; 79(1):91-5. PubMed ID: 9495365 [TBL] [Abstract][Full Text] [Related]